Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1680 of 6351
-
Experimental CAR-T therapy takes on stubborn cancers
Disease control Recruiting nowThe investigational product used in this study, UCLH801 cells, is a CAR-T cell therapy specifically targeting CDH17. The proposed indication includes CDH17-positive advanced solid tumors, such as but not limited to colorectal cancer, gastric cancer, pancreatic cancer, biliary tra…
Early phase 1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Needle-Free epinephrine film could transform emergency allergy care for kids
Disease control CompletedAn open-label study to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of epinephrine administered as a single dose of DESF in pediatric subjects weighing ≥30 kg with a personal history of allergic reactions and are at high risk for serious aller…
Phase 1 • Sponsor: Aquestive Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New imaging method aims to spot rare childhood and adult cancers without surgery
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate the diagnostic efficacy of somatostatin receptor and norepinephrine transporter targeted imaging (including 18F-MFBG, 123I-MIBG, 131I-MIBG, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE, 68Ga-DOTA-TOC, and other radiolabeled somatostatin analogues) …
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
One shot to tame blood pressure? new drug HRS-9563 heads into first human test
Disease control CompletedTo evaluate the safety and tolerability of a single subcutaneous injection of HRS-9563 in hypertensive subjects
Phase 1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for rare lymphoma: targeted drug enasidenib enters phase 2 trial
Disease control OngoingThe researchers are doing this study to find out whether enasidenib is a safe treatment for people with angioimmunoblastic T-cell lymphoma (AITL) that has an IDH2 mutation. The researchers will look at the safety of enasidenib when it is given alone or in combination with the dru…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Zapping the brain to beat meth cravings: new trial launches
Disease control Recruiting nowTo investigate the mechanism and efficacy of a novel repetitive transcranial magnetic stimulation (rTMS) intervention model with paired cerebellar-medial prefrontal cortex (mPFC) pulses on methamphetamine use disorder patients and to develop a novel physiotherapeutic intervention…
Sponsor: Shanghai Mental Health Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug aims to stop hip bone death from steroids
Disease control OngoingThis is a multicenter, randomized (similar to drawing lots, where the treatment you receive is not chosen by you or the researchers), controlled, blinded (the three dose groups of the investigational drug are blinded, meaning neither you nor the blinded researchers will know whic…
Phase 2 • Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a natural supplement soothe an upset stomach?
Symptom relief CompletedThis clinical trial aims to determine whether Meu-cinn promotes gastric mucosal health in adults with functional dyspepsia and to assess its safety. The main questions are: * Does Meu-cinn promote gastric mucosal health in participants? * What side effects occur when participan…
Sponsor: Pusan National University Yangsan Hospital • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
A 5-minute quiz might predict who gets severe chemo side effects
Knowledge-focused CompletedThe goal of this observational study is to learn about the impact of chemotherapy-related toxicity on older cancer patients in China. The main question it aims to answer is: Does the Cancer and Aging Research Group (CARG) chemotherapy toxicity risk score predict chemotherapy-rel…
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Scarless hysterectomy: new vaginal surgery may cut complications for large uteri
Symptom relief Recruiting nowIn France, there are approximately 62,000 hysterectomies per year, 70% of which are benign. It is the most frequent surgical procedure in gynecology. Hysterectomies are performed via 3 routes: laparotomy, laparoscopy or vaginal route. This choice of approach is particularly imp…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Gene therapy injection aims to save sight in rare eye disease
Disease control Recruiting nowThis is a single-arm, open-label, non-randomized, single dose-escalation, first-in-human (FIH) clinical trial to evaluate the safety and preliminary efficacy of VG801 for treatment of patients with retinal dystrophy (Stargardt disease) due to biallelic ABCA4 mutations.
Phase 1/2 • Sponsor: VeonGen Therapeutics GmbH • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Last-resort melanoma combo shows early promise in small trial
Disease control Recruiting nowThis is a phase 2, single-arm, open label clinical trial determining efficacy of Cyclophosphamide and Pembrolizumab in subjects with melanoma.
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
MRNA therapy takes on autoimmune diseases in early trial
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, as well as preliminary efficacy of mRNA encoding CD19/CD3 T cell engager (ABO2203) in patients with refractory autoimmune diseases who received inadequate response or relapsed f…
Early phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a natural amino acid shorten sickle cell pain crises? new trial aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if intravenous citrulline works to treat acute pain in hospitalized patients with sickle cell disease. It will also learn about the safety of intravenous citrulline. The main questions it aims to answer are: * Does intravenous citrulli…
Phase 2 • Sponsor: Suvankar Majumdar • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could stem cells save failing kidneys? mayo clinic launches new trial
Disease control Recruiting nowThe purpose of this protocol is to treat an intermediate-sized population with chronic kidney disease (CKD) including kidney transplant recipients. The protocol uses allogeneic bone marrow-derived mesenchymal stem cells (MSCs). MSC infusion may be delivered 1) intravenous or 2) i…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common diuretic protect hearts in rare ARVD?
Disease control Recruiting nowArrhythmogenic right ventricular dysplasia (ARVD) is a rare cardiomyopathy characterized by the progressive replacement of cardiomyocytes by fatty and fibrous tissue in the right ventricle (RV). These infiltrations lead to cardiac electrical instability and ventricular arrhythmia…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Blood test may end guesswork in psoriasis dosing
Disease control Recruiting nowBiologics are effective agents for the treatment of psoriasis. The newest generation of biologics block interleukin 17 and 23. Physicians always prescribe these drugs in a fixed dose, but this may lead to under- and overdosing in some patients. Underdosing may lead to inadequate …
Phase 4 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New blood test could personalize breast cancer care
Diagnosis Recruiting nowDevelopment and validation of an integrated testing strategy for simultaneous detection of ESR-1 and gBRCA mutations via liquid biopsy in HR+/HER2- metastatic breast cancer (mBC) patients, and the creation of a digital gene library to support an evidence-based diagnostic algorith…
Sponsor: European Institute of Oncology • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Robot walks could ease nerve pain in spinal injury patients
Symptom relief OngoingThe goal of this feasibility trial is to learn if exoskeleton or robotic walking works to reduce nerve (neuropathic) pain after spinal cord injury. This study asks is: * Providing walking practice through use of a robotic device (exoskeleton) three times per week for twelve wee…
Sponsor: University College Dublin • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New pill shows promise for shedding pounds in obesity trial
Disease control CompletedPhase 2 clinical study will evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of various aleniglipron (GSBR-1290) dose regimens compared with placebo in participants living with obesity or overweight with ≥ 1 weight-related comorbidity, in addition to diet an…
Phase 2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC